Betterlife Pharma Inc. balance sheet BETRF

Annual Quarterly

As of Oct 31, 2018, Betterlife Pharma Inc. had total assets of $7.1 million. Total assets were up 1222.9% from a year earlier. Stockholders' equity was $3.4 million. Cash and investments were $406,901. The current ratio, current assets divided by current liabilities, was 0.15.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

Line	FY 2019 Oct 31, 2018	FY 2018 Jan 31, 2018	FY 2017 Jan 31, 2017	FY 2016 Jan 31, 2016	FY 2016 Jan 31, 2015	FY 2012 Jan 31, 2013	FY 2011 Jul 31, 2011
Assets
Cash	0 +62.5%	0 -42.6%	0 +13299.4%	0	0	0 -77.0%	0
Cash and investments	0 +62.5%	0 -42.6%	0 +13299.4%	0	0	0 -77.0%	0
Inventory	0	—	—	—	—	—	—
Total current assets	1 +87.9%	0 +15.0%	0 +13733.5%	0	0	0 +129.5%	0
Property and equipment, net	0	—	—	—	0	0 -25.5%	0
Total assets	7 +1222.9%	0 +189.3%	0 +10386.8%	0	0	0 +57.6%	0
Liabilities and equity
Total current liabilities	4 +2333.6%	—	2	—	—	1 -23.5%	1
Total liabilities	—	0	—	0	0	1 -33.7%	1
Stockholders' equity	3 +1774.4%	-0 +96.9%	-1 -348.1%	-0	—	-1 +34.1%	-1
Ratios
Current ratio	0.15x	—	0.08x	—	—	0.01x	0.00x
Return on equity	-196.65%	—	—	—	—	—	—
Return on assets	-95.24%	-31.57%	-4,732.63%	-9,713.11%	-814,787.75%	5,636.87%	36,881.74%
Book value per share	0.04	-0.00	-0.02	-0.00	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: BETRF (OTC)
Fiscal year ends: January 31
Incorporated in: British Columbia, Canada
Headquarters: Vancouver, British Columbia, Canada
SEC filer status: Non-accelerated filer
SEC CIK: 1464165
Former names: Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.